Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors
Authors:
- Serdar KahramanSKSerdar Kahraman
- Mehmet Salih DeveciMDMehmet Salih Deveci
- Ozgur YesilyurtOYOzgur Yesilyurt
- Ahmet DogrulADAhmet Dogrul
- 1 December 2010
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 649 (1-3) , 183-194
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Locomotor-Activated Neurons of the Cat. I. Serotonergic Innervation and Co-Localization of 5-HT7, 5-HT2A, and 5-HT1A Receptors in the Thoraco-Lumbar Spinal CordJournal of Neurophysiology, 2009
- Human 5-HT7 Receptor-Induced Inactivation of Forskolin-Stimulated Adenylate Cyclase by Risperidone, 9-OH-Risperidone and Other “Inactivating Antagonists”Molecular Pharmacology, 2009
- Descending control of nociception: Specificity, recruitment and plasticityBrain Research Reviews, 2009
- Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating AntagonistsMolecular Pharmacology, 2009
- Gz Mediates the Long-Lasting Desensitization of Brain CB1 Receptors and is Essential for Cross-Tolerance with MorphineMolecular Pain, 2009
- Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRIBritish Journal of Pharmacology, 2008
- Inhibition of opioid release in the rat spinal cord by serotonin 5-HT1A receptorsBrain Research, 2007
- Endocannabinoid mechanisms of pain modulationThe AAPS Journal, 2006
- Systemic morphine produce antinociception mediated by spinal 5‐HT7, but not 5‐HT1A and 5‐HT2 receptors in the spinal cordBritish Journal of Pharmacology, 2006
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983